Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

August 31, 2015

Conditions
Pediatric Patient (1m-21y)ICU AdmissionHyperglycemia
Interventions
OTHER

Active Glycemic Control Strict (80-140mg/dL) vs. Conservative (190-220mg/dL) (with or without Continuous Glucose Monitoring)

In addition to glycemic control in 2 groups, all children \<1 year old and 25% of those \>1 year old, will be able to receive continuous glucose monitoring via interstitial glucometry.

Trial Locations (1)

30322

Children's Healthcare of Atlanta at Egleston, Atlanta

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Children's Healthcare of Atlanta

OTHER

lead

Indiana University

OTHER